Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

301.42
-6.5800-2.14%
Post-market: 301.420.00000.00%16:20 EDT
Volume:335.34K
Turnover:102.14M
Market Cap:13.60B
PE:12.01
High:313.35
Open:308.26
Low:301.23
Close:308.00
Loading ...

United Therapeutics Price Target Maintained With a $425.00/Share by HC Wainwright & Co.

Dow Jones
·
05 May

Court dismisses United Therapeutics’ dispute against Liquidia

TIPRANKS
·
03 May

Liquidia rallies after judge rules against bid to delay Yutrepia

TIPRANKS
·
03 May

United Therapeutics First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
02 May

United Therapeutics Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
02 May

UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales

Zacks
·
01 May

U.S. RESEARCH ROUNDUP-Avepoint, Meta, United Therapeutics

Reuters
·
01 May

Q1 2025 United Therapeutics Corp Earnings Call

Thomson Reuters StreetEvents
·
01 May

United Therapeutics Corp : JP Morgan Cuts Target Price to $350 From $355

THOMSON REUTERS
·
01 May

Stock Track | United Therapeutics Soars 5.43% Pre-Market on Strong Q1 Earnings Beat and Robust Revenue Growth

Stock Track
·
30 Apr

Stock Track | United Therapeutics Soars 5.43% on Strong Q1 Results and Positive Outlook

Stock Track
·
30 Apr

United Therapeutics Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
30 Apr

United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
30 Apr

United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

Zacks
·
30 Apr

United Therapeutics Q1 Earnings, Revenue Rise

MT Newswires Live
·
30 Apr

United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

StockStory
·
30 Apr

United Therapeutics reports Q1 EPS $6.63, consensus $6.28

TIPRANKS
·
30 Apr

United Therapeutics: Q1 Earnings Snapshot

Associated Press Finance
·
30 Apr

United Therapeutics Q1 EPS $6.63 Beats $6.52 Estimate, Sales $794.40M Beat $729.83M Estimate

Benzinga
·
30 Apr

BRIEF-United Therapeutics Q1 Revenue USD 794.4 Million Vs. IBES Estimate USD 729.8 Million

Reuters
·
30 Apr